Lessee, Operating Lease, Liability, to be Paid, Year Four of FibroBiologics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
FibroBiologics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
  • FibroBiologics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2025 was $355,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

FibroBiologics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $355,000 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $353,000 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $351,000 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q4 2023 $509,000 31 Dec 2023 10-K 29 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.